The suppressing effects of VEGF-mediated angiogenesis at different administration sequences of apatinib and transarterial embolization in vivo
Author(s) -
Nan Li,
Yonghui Huang
Publication year - 2020
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2019.12.97
Subject(s) - apatinib , medicine , angiogenesis , vascular endothelial growth factor , gastroenterology , hepatocellular carcinoma , urology , liver cancer , embolization , vegf receptors , in vivo , cancer , surgery , biology , microbiology and biotechnology
Department of Interventional Radiology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China Contributions: (I) Conception and design: YH Huang, N Li; (II) Administrative support: YH Huang; (III) Provision of study materials or patients: N Li; (IV) Collection and assembly of data: N Li; (V) Data analysis and interpretation: YH Huang, N Li; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Dr. Yong-Hui Huang; Dr. Nan Li. Department of Interventional Radiology, the First Affiliated Hospital, Sun Yat-sen University, 58th Zhongshan Road II, Guangzhou 510080, China. Email: cir.huangyonghui@vip.163.com; zsylinan@163.com.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom